Skip to main content
NCBI home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2009 Feb 3;21(12):893–898. doi: 10.1002/clc.4960211207

The effects of an angiotensin‐converting inhibitor (enalapril) on patients with mild cardiac failure—evaluating cardiac function based on the relationship between daily walking pace and heart rate

Eji Ino‐Oka 1,✉, Showko Umeda 1, Yoshiharu Kutsuwa 1, Takashi Takahashi 1, Kouichi Sagawa 2, Takayuki Takahashi 2, Hikaru Inooka 2
PMCID: PMC6656159  PMID: 9853181

Abstract

Background: Heart failure has been evaluated by several methods, the New York Heart Association (NYHA) classification of heart failure based on symptoms being used most frequently. However, the degree of heart failure assessed by these criteria does not always correlate with cardiac function in daily life.

Hypothesis: The aim of the study was to evaluate cardiac function based on the walking pace/heart rate (HR) relationship to assess the effects of enalapril, an angiotensin‐converting enzyme inhibitor, in patients with mild to moderate cardiac function.

Methods: To evaluate cardiac function objectively, we developed a method using a pedometer to count the steps walked while simultaneously recording HR using a Holter electrocardiograph (ECG). Step‐count walk rate (WR) was recorded on the magnetic tape of the Holter apparatus, and both HR and walking pace were calculated automatically by the Holter ECG analysis system. Data were determined every hour, and mean pace and HR were plotted along the x and y axes, respectively. The slope of HR X WR was calculated using the least squares method. The slope and the total number of steps were regarded as indicators of cardiac function and quality of life, respectively. We analyzed 36 subjects, consisting of 8 normal volunteers, 8 patients in New York Heart Association (NYHA) class 1,11 in class II, and 9 in class III chronic mild heart failure, during maximal exercise work load by bicycle ergometer; furthermore, fractional shortening of the left ventricle on echocardiogram was determined in 14 patients with chronic mild heart failure and was compared with the slope of HR X WR. Enalapril was administered at a daily dose of 2.5‐10 mg for 1‐24 months (mean 6 months) in 60 patients to evaluate the effects of this drug on these parameters.

Results: There was a significant inverse relationship between maximal work load and the HR X WR slope, and also between the fractional shortening and the slope, suggesting that the slope may reflect the severity of cardiac dysfunction. Furthermore, the slope decreased significantly from 1.8 ± 1.26 before enalapril to 1.0 ± 0.94 (mean ± standard deviation) after drug administration, while the total number of steps increased significantly from 4842 ± 3581 to 7804 ± 4793.

Conclusion: The slope of the graph relating step count and HR proved to be a good, objective indicator of cardiac function, and enalapril therapy improved this parameter.

Keywords: heart failure, cardiac function, Holter electrocardiogram, exercise‐heart rate response, walking pace‐heart rate relationship

Full Text

The Full Text of this article is available as a PDF (628.5 KB).

REFERENCES

  • 1. The Criteria Committee of the New York Heart Association : Nomenclature and Criteria for Diagnosis of Disease of the Heart and Great Vessels, 9th. ed., p. 253–256. Boston, Mass.: Little, Brown & Company, 1994. [Google Scholar]
  • 2. Goldman L, Hashimoto B, Cook EF, Loscalzo A: Comparative re‐producibilily and validity of systems for assessing cardiovascular functional class: Advantages of new specific activity scale. Circulation 1981; 64: 1227–1234 [DOI] [PubMed] [Google Scholar]
  • 3. Jafri SM, Lakier JB, Rosman HS, Peterson E, Goldstein S: Symptoms and tests of ventricular performance in the evaluation of chronic heart failure. Am Heart J 1986; 112: 194–196 [DOI] [PubMed] [Google Scholar]
  • 4. Massie BM, Conway M: Survival of patients with congestive heart failure: Past, present and future prospects. Circulation 1987; 75 (suppl): IV‐11–IV‐19 [PubMed] [Google Scholar]
  • 5. Likoff MI, Chandler SL, Key HR: Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1986; 59: 634–638 [DOI] [PubMed] [Google Scholar]
  • 6. Packer M: Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure. Am J Cardiol 1989; 63: 41A–45A [DOI] [PubMed] [Google Scholar]
  • 7. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R: A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989; 320: 677–683 [DOI] [PubMed] [Google Scholar]
  • 8. Uretsky BF, Jessup M, Konstam MA, Dei GW, Leier CV, Benotti J, Murali S, Herrmann, HC , Scandberg JA: Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure: Lack of benefit compared to placebo. Circulation 1990; 82: 774–780 [DOI] [PubMed] [Google Scholar]
  • 9. Massie B, Bourassa M, Dibianco R, Hess M, Konstam M, Linkoff M, Packer M: Long‐term oral administration of amrinone for congestive heart failure: Lack of efficacy in a multicenter controlled trial. Circulation 1985; 71: 963–971 [DOI] [PubMed] [Google Scholar]
  • 10. Elkayam U, Amin J, Mehra A, Vasqez J, Weber L, Rahimtoola SH: A prospective, randomized, double‐blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation 1990; 82: 1954–1961 [DOI] [PubMed] [Google Scholar]
  • 11. Ino‐Oka E, Takahashi T, Sagawa K, Inooka H: Diagnosis of silent myocardial ischemia using ambulatory electrocardiographic monitoring with pedometer, analysis of heart rate, and ST loop in ambulatory electrocardiogram. Clin Cardiol 1996; 19: 467–472 [DOI] [PubMed] [Google Scholar]
  • 12. Yamanaka N, Sagawa K, Takahashi T, Ishihara M, Ino‐Oka H, Takahashi T: Development of a long‐term walk measuring system. Proc Symp Lang‐Term Imm Meas Anal of Phys Sig 1990; 16: 217–220 [Google Scholar]
  • 13. Naganuma F, Kubota S, Hirahara N, Imai K, Kamiyama H, Lizuka T, Imai S, Murata K, Suzuki T: Ventricular unloading and improvement in left ventricular function after angiotensin converting enzyme inhibition with enalapril in patients with chronic congestive heart failure. Jpn Circ J 1994; 58: 34–42 [DOI] [PubMed] [Google Scholar]
  • 14. Brilla CG, Krämer B, Hoffmeister HM, Müller‐Schauenburg W, Risler T, Seipel L: Low‐dose enalapril in severe chronic heart failure. Cardiovasc Drug Ther 1989; 3: 211–218 [DOI] [PubMed] [Google Scholar]
  • 15. Rector TS, Kubo SH, Cohn JN: Patients' self‐assessment of their congestive heart failure: Part 2. Content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987; 3: 198–209 [Google Scholar]
  • 16. Franciosa JA: Why patients with congestive heart failure die: He‐modynamic and functional determinants of survival. Circulation 1987; 75 (suppl): IV‐20–IV‐27 [PubMed] [Google Scholar]
  • 17. Packer M, Leiner CV: Survival in congestive heart failure during treatment with drugs with positive inotropic actions. Circulation 1987; 75 (suppl): IV‐55–IV‐63 [PubMed] [Google Scholar]
  • 18. Simonton CA, Daly, PA , Kereiakes D, Modin G, Chatterjee K: Survival in severe left ventricular failure treated with the new non‐glycosidic nonsympathomimetic oral inotropic agents. Chest 1989; 92: 118–123 [DOI] [PubMed] [Google Scholar]
  • 19. McGreger M, Klassen GA: Observations on the effect of heart rate on cardiac output in patients with complete heart block at rest and during exercise. Circ Res 1964; 14/15 (suppl II): II‐215–II‐224 [PubMed] [Google Scholar]
  • 20. Ikkos D, Hanson JS: Response in congenital complete atrioventricular block. Circulation 1960; 22: 583–590 [DOI] [PubMed] [Google Scholar]
  • 21. Edhang O, Zetterquist S: Peripheral circulatory adaptation to exercise in restricted cardiac output. Scand J Clin Lab Invest 1968; 21: 123–135 [DOI] [PubMed] [Google Scholar]
  • 22. McElroy PA, Janicki JS, Weber KT: Physiologic correlation of the heart rate response to upright isotonic exercise: Relevance to rate‐responsive pacemakers. J Am Coll Cardiol 1988; 11: 94–99 [DOI] [PubMed] [Google Scholar]
  • 23. Reddy HK, McElroy PA, Janicki JS, Weber KT: Response in oxygen uptake and ventilation during stair climbing in patients with chronic heart failure. Am J Cardiol 1989: 63: 222–225 [DOI] [PubMed] [Google Scholar]
  • 24. Insel J, Boland DM, Cinquegrani MJ: Acute haemodynamic effects of benazepril, a new oral long acting angiotensin converting enzyme inhibitor, in patients with severe congestive heart failure (abstr). Clin Res 1988; 36: 36A [Google Scholar]
  • 25. Cohn JN: A comparison of enalapril with hydralazine‐isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303–310 [DOI] [PubMed] [Google Scholar]
  • 26. The CONSENSUS Trial Study Group : Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429–1435 [DOI] [PubMed] [Google Scholar]
  • 27. The SOLVD Investigators : Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991; 325: 293–302 [DOI] [PubMed] [Google Scholar]
  • 28. The SOLVD Investigators : Effect of enalapril on mortality and the development of heart failure in symptomatic patients with reduced left ventricular ejection. N Engl J Med 1992; 327: 685–691 [DOI] [PubMed] [Google Scholar]
  • 29. Pfeffer MA, Braunwald E: Effect of enalapril on mortality in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669–677 [DOI] [PubMed] [Google Scholar]
  • 30. Colfer HT, Ribner HS, Gradman A: Effects of once‐daily benazepril therapy on exercise tolerance and manifestations of chronic congestive heart failure. Am J Cardiol 1992; 70: 354–358 [DOI] [PubMed] [Google Scholar]
  • 31. The Captopril Digoxin Multicenter Research Group : Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure J Am Med Assoc 198; 259: 539–544 [PubMed] [Google Scholar]
  • 32. Townend JN, Litler WA: Angiotensin converting enzyme inhibitors in heart failure: How good are they? Br Heart J 1993; 69: 373–375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Norderhaug JE, Vollset SE: Reduction of exercise induced ventricular arrhythmias in mild symptomatic heart failure by benazepril. Am Heart J 1993; 125: 771–776 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES